1. Home
  2. SSYS vs GOSS Comparison

SSYS vs GOSS Comparison

Compare SSYS & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratasys Ltd. (Israel)

SSYS

Stratasys Ltd. (Israel)

HOLD

Current Price

$11.05

Market Cap

944.9M

Sector

Technology

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$2.73

Market Cap

796.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSYS
GOSS
Founded
1989
2015
Country
United States
United States
Employees
1779
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
944.9M
796.2M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
SSYS
GOSS
Price
$11.05
$2.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$12.75
$8.83
AVG Volume (30 Days)
1.2M
4.6M
Earning Date
03-04-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$561,461,000.00
$44,051,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.76
$6.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.12
$0.76
52 Week High
$12.88
$3.87

Technical Indicators

Market Signals
Indicator
SSYS
GOSS
Relative Strength Index (RSI) 60.40 46.08
Support Level $10.74 $2.38
Resistance Level $11.69 $3.00
Average True Range (ATR) 0.63 0.22
MACD 0.12 0.02
Stochastic Oscillator 61.54 56.24

Price Performance

Historical Comparison
SSYS
GOSS

About SSYS Stratasys Ltd. (Israel)

Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: